A legal complaint was filed against Alvotech for the Icelandic pharmaceutical company’s alleged misappropriation of trade secrets involving the development of a generic version of AbbVie’s rheumatoid arthritis drug Humira.
Boston Scientific will pay $189 million to settle a multi-state lawsuit over the marketing of the company’s surgical mesh devices.
Leading life science commercialization partner Fishawack Health acquired PRMA Consulting, a premier global market access and health economics outcomes research (HEOR) consultancy with offices across Europe, Asia, and the United States.
Precision Value & Health, an industry leader for commercialization services for innovative life science companies, on March 24 announced the acquisition of Across Health, a leading global omnichannel engagement consultancy focused on providing clients an analytical and evidence-based framework for commercial strategy, execution and resource optimization.
A large plant being used to manufacture Johnson & Johnson’s Covid-19 vaccine was cleared by U.S. regulators on March 23, setting the stage for the weekly U.S. supply to surge more than 20 percent.
Med Ad News talked with Ed Mitzen, Founder of Fingerpaint, and Brannon Cashion, a Managing Partner at Leaderboard Branding, about the reasons why the agency decided to make a strategic investment in Leaderboard, a global naming and branding business headquartered in Charlotte, N.C. Mitzen and Cashion discussed how the two companies complement each other and how the connection with Leaderboard will expand the services Fingerpaint can offer clients.
Fingerpaint, a full-service health and wellness marketing agency, executed a strategic investment in Leaderboard Branding, a leading global naming and branding business headquartered in Charlotte, N.C., to grow its portfolio of companies.
FUJIFILM selected the town of Holly Springs, North Carolina, as the company’s spot to build the largest cell culture biopharmaceutical production facility in North America.
Pennsylvania-based Ocugen struck a deal to sell 100 million doses of a Covid-19 vaccine.
The U.S. Federal Trade Commission (FTC) formed a multinational working group to evaluate pharmaceutical mergers.
